CEREBROVASCULAR MITOCHONDRIA AS MEDIATORS OF NEUROINFLAMMATION IN ALZHEIMER'S DISEASE - ABSTRACT IN ALZHEIM…
Federal financial assistance recorded from USAspending. This is not a procurement contract.
Assistance award details
- Assistance award identifier
- ASST_NON_R00AG083227_075
- FAIN
- R00AG083227
- Recipient
- UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS
- Awarding agency
- Department of Health and Human Services
- Funding agency
- Department of Health and Human Services
- Assistance listing (CFDA)
- 93.866
- Total obligated
- $248,999
- Period
- Aug 1, 2023 – Jan 31, 2029
- Fiscal year
- 2026
- Place of performance state
- PR
- Source file
- FY2026_All_Assistance_Full_20261006.zip
Description
CEREBROVASCULAR MITOCHONDRIA AS MEDIATORS OF NEUROINFLAMMATION IN ALZHEIMER'S DISEASE - ABSTRACT IN ALZHEIMERâS DISEASE (AD), AND TO A LESSER EXTENT IN NON-DEMENTED INDIVIDUALS, DEPOSITION OF AMYLOID Î (AÎ) IS FOUND AROUND CEREBRAL VESSELS, A CONDITION CALLED CEREBRAL AMYLOID ANGIOPATHY (CAA). IT IS LIKELY THAT THE DEVELOPMENT OF CAA, AND CONSEQUENTLY NEUROVASCULAR UNIT (NVU) DYSFUNCTION, IN AD MAY RESULT FROM FAILURE OF AÎ CLEARANCE PATHWAYS. IMPORTANTLY, ALL AÎ CLEARANCE PATHWAYS INVOLVE MOVEMENT OF AÎ TOWARDS THE VASCULATURE FOR ELIMINATION. CEREBROVASCULAR ENDOTHELIAL CELLS (EC), WHICH LINE ALL BRAIN VESSELS, ARE THE GATEKEEPERS OF THE BRAIN AND ARE RESPONSIBLE FOR THE MAINTENANCE OF CEREBRAL HOMEOSTASIS THROUGH THE BLOOD-BRAIN BARRIER (BBB). THE DEVELOPMENT OF CAA SEVERELY IMPACTS BRAIN HEALTH SINCE IT RESULTS IN EC DEATH, BBB BREAKDOWN, MICROHEMORRHAGES, PARENCHYMAL AÎ ACCUMULATION, AND IS ONE OF THE EARLIEST TRIGGERS FOR AD PROGRESSION. EC DYSFUNCTION ALSO AFFECTS OTHER CELLS OF THE NVU, SUCH AS ASTROCYTES OR MICROGLIA, THROUGH FINELY REGULATED COMMUNICATION MECHANISM BETWEEN THESE CELLS. THEREFORE, CAA-MEDIATED EC DYSFUNCTION MAY ALSO PRECIPITATE NEUROINFLAMMATION IN AD. OUR PRELIMINARY DATA SUGGESTS THAT EC MITOCHONDRIA SERVE AS IMPORTANT SENSORS OF AÎ DAMAGE. PREVIOUS STUDIES HAVE SHOWN THAT MITOCHONDRIA ARE RESPONSIBLE FOR THE ACTIVATION OF INFLAMMATORY PATHWAYS THROUGH THE RELEASE OF MITOCHONDRIAL DANGER ASSOCIATED MOLECULAR PATTERNS (MTDAMPS), INCLUDING MITOCHONDRIAL REACTIVE OXYGEN SPECIES (MTROS), DUE TO FORMATION OF THE PATHOLOGICAL MITOCHONDRIAL PERMEABILITY TRANSITION PORE (MPTP). BOTH CEREBROVASCULAR DYSFUNCTION AND INFLAMMATION ARE SHOWN EARLY IN DISEASE PATHOGENESIS, SUGGESTING THAT EARLY EC (AND THUS, BBB) DYSFUNCTION MAY DRIVE AND PERPETUATE AD PATHOLOGY ALSO BY TRIGGERING WIDESPREAD NEUROINFLAMMATION. HERE, WE WILL TEST THE HYPOTHESIS THAT AÎ INDUCES MITOCHONDRIAL DYSFUNCTION IN CEREBRAL ECS THROUGH DELETERIOUS ALTERATIONS IN MITOCH